{"id":"https://openalex.org/W2005476090","doi":"https://doi.org/10.1016/j.ijpharm.2007.09.042","title":"Method for screening of solid dispersion formulations of low-solubility compounds\u2014Miniaturization and automation of solvent casting and dissolution testing","display_name":"Method for screening of solid dispersion formulations of low-solubility compounds\u2014Miniaturization and automation of solvent casting and dissolution testing","publication_year":2007,"publication_date":"2007-10-11","ids":{"openalex":"https://openalex.org/W2005476090","doi":"https://doi.org/10.1016/j.ijpharm.2007.09.042","mag":"2005476090","pmid":"https://pubmed.ncbi.nlm.nih.gov/18054181"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2007.09.042","doi":"https://doi.org/10.1016/j.ijpharm.2007.09.042","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2007.09.042","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036448960","display_name":"Anant Shanbhag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A SHANBHAG","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090051877","display_name":"Shelley R. Rabel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S RABEL","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070206010","display_name":"Ewa Nauka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E NAUKA","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027532542","display_name":"Gemma Casadevall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G CASADEVALL","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111573115","display_name":"Pandey Shivanand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P SHIVANAND","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012694242","display_name":"Gary M. Eichenbaum","orcid":"https://orcid.org/0000-0002-2318-6042","observed_orcids":["https://orcid.org/0000-0002-2318-6042"]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G EICHENBAUM","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013400146","display_name":"Paul A. Mansky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153281","display_name":"Alexza Pharmaceuticals (United States)","ror":"https://ror.org/04vnkt240","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153281"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"P MANSKY","raw_affiliation_strings":["Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, USA","institution_ids":["https://openalex.org/I4210153281"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013400146"],"corresponding_institution_ids":["https://openalex.org/I4210153281"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.4431,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.75915266,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"351","issue":"1-2","first_page":"209","last_page":"218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solid-dispersion","display_name":"solid dispersion","score":0.9079999923706055},{"id":"https://openalex.org/keywords/low-solubility-drugs","display_name":"low solubility drugs","score":0.8320000171661377},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.6650000214576721},{"id":"https://openalex.org/keywords/solvent-casting","display_name":"solvent casting","score":0.7689999938011169},{"id":"https://openalex.org/keywords/miniaturization","display_name":"miniaturization","score":0.7580000162124634},{"id":"https://openalex.org/keywords/96-well-plate","display_name":"96-well plate","score":0.7289999723434448},{"id":"https://openalex.org/keywords/dissolution-testing","display_name":"dissolution testing","score":0.6269999742507935},{"id":"https://openalex.org/keywords/polymers","display_name":"polymers","score":0.8309999704360962},{"id":"https://openalex.org/keywords/surfactants","display_name":"surfactants","score":1.0},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.5559999942779541},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7170000076293945},{"id":"https://openalex.org/keywords/simulated-intestinal-fluid","display_name":"simulated intestinal fluid","score":0.578000009059906},{"id":"https://openalex.org/keywords/scale-up","display_name":"scale-up","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.8683043122291565},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.8045548796653748},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.7009549736976624},{"id":"https://openalex.org/C64452783","wikidata":"https://www.wikidata.org/wiki/Q1524945","display_name":"Ternary operation","level":2,"score":0.6501757502555847},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6115294694900513},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.6033750772476196},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.5860697031021118},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.5387962460517883},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5350856184959412},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.5138030648231506},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.5110052824020386},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48931214213371277},{"id":"https://openalex.org/C177562468","wikidata":"https://www.wikidata.org/wiki/Q182893","display_name":"Dispersion (optics)","level":2,"score":0.4559843838214874},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.4156801998615265},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.17873796820640564},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.07873415946960449},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07351425290107727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.05795910954475403},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001331","descriptor_name":"Automation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008904","descriptor_name":"Miniaturization","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ijpharm.2007.09.042","doi":"https://doi.org/10.1016/j.ijpharm.2007.09.042","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2007.09.042","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:18054181","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18054181","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W70108856","https://openalex.org/W97031821","https://openalex.org/W115516873","https://openalex.org/W120975518","https://openalex.org/W252369352","https://openalex.org/W1967935934","https://openalex.org/W1990265072","https://openalex.org/W1992262534","https://openalex.org/W1995383798","https://openalex.org/W1997764055","https://openalex.org/W2008223612","https://openalex.org/W2021511813","https://openalex.org/W2029846190","https://openalex.org/W2040442327","https://openalex.org/W2044493918","https://openalex.org/W2044594845","https://openalex.org/W2068771102","https://openalex.org/W2072432140","https://openalex.org/W2076602731","https://openalex.org/W2077435670","https://openalex.org/W2083025208","https://openalex.org/W2094199150","https://openalex.org/W2167286960","https://openalex.org/W2169909726","https://openalex.org/W2409179223"],"related_works":["https://openalex.org/W2068771102","https://openalex.org/W2052446737","https://openalex.org/W2768590269","https://openalex.org/W2008386762","https://openalex.org/W2078542292","https://openalex.org/W2105629610","https://openalex.org/W4417080362","https://openalex.org/W2107566417","https://openalex.org/W2517200902","https://openalex.org/W7222299530"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}